DERMATOMYOSITIS

This study looked at the long-term safety and effectiveness of a drug called KZR-616 in 18 adults with active polymyositis or dermatomyositis, rare diseases that cause muscle inflammation and weakness. Participants had already completed a previous study and continued taking KZR-6…

This study tested an experimental drug called KZR-616 in 25 adults with active polymyositis or dermatomyositis, two rare diseases that cause muscle inflammation and weakness. Participants received weekly injections of the drug or a placebo for 16 weeks, then switched to the other…

This study looked at whether whole body magnetic resonance imaging (MRI) can correctly identify inflammatory muscle diseases like myositis. Researchers tested 139 people with suspected muscle inflammation to see how well MRI results matched the standard method of muscle biopsy. T…

This study tested whether a custom rehabilitation program can improve daily function and quality of life for people with dermatomyositis or polymyositis, two rare diseases that cause muscle inflammation and weakness. Eighty adults with stable muscle impairment took part. The prog…

This study looked at why some military personnel develop myositis, a rare disease where the immune system attacks muscle tissue, causing weakness and pain. Researchers compared 37 people—some with myositis and some healthy—using questionnaires and blood samples to find possible e…

This study looked at what causes autoimmune diseases that affect muscles and connective tissues, like myositis. Researchers studied 719 people, including patients, their relatives, and healthy volunteers, to find genetic and environmental risk factors. Participants gave blood sam…

This study looked at a simple, low-cost test called the Myositis Functional Index-3 (FI-3) to see if it accurately measures muscle function in people with inflammatory myopathies (diseases that cause muscle weakness). Researchers compared it to advanced machines and also tested a…